ONCO: Prakiraan rega marang bathi Onconetix

ONCO (Onconetix, Inc.) - tandha merek perusahaan

Onconetix, Inc. (ONCO) faces debt pressure and competition in oncology urology, yet minimizes operational disruptions through an extensive network of external laboratories. The company's forward P/E clearly demonstrates market expectations, where the 0.00 level indicates the status of the valuation parameter. The business's financial stability relies exclusively on grants and the outcomes of current clinical trials.

Kapitalisasi marang proyeksi bathi: onconetix.gcs-web.com (ONCO) kanggo 21.02.2024 - 16.11.2026

Rincian analitis lan laporan data perusahaan onconetix.gcs-web.com (ONCO)

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:ONCO Onconetix, Inc.
Produk mawa merek Onconetix, Inc.

The commercialization of Entadfi and the development of the urological pipeline at Onconetix, Inc. (ONCO) drive the company's future NTM P/E dynamics, reflecting market earnings expectations within a high-margin segment. This indicator compares the business's market value with projected net income, allowing investors to assess whether the asset is overvalued or to identify hidden bankruptcy risks through an analysis of the capital safety margin.

Karo sapa Onconetix, Inc. saingan

Pangali Forward P/E A|DGX - Rasio prakiraan rega marang bathi|Illumina Inc - Prakiraan rega marang bathi|exactsciences.com (EXAS) - Rasio prakiraan rega marang bathi|RVTY - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Bio-Rad Laboratories, Inc. BIO|NNNN: Pangali Forward P/E|SHC - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep quidel.com|Rasio prakiraan rega marang bathi opko.com OPK|Pangali Forward P/E CDNA|Prakiraan rega marang bathi Maravai LifeSciences Holdings, Inc. MRVI|Fulgent Genetics Inc - Prakiraan rega marang bathi|Pangali Forward P/E Standard BioTools Corp LAB|CTKB: Prakiraan rega marang bathi|OSUR - Pangali Forward P/E|XGN: Pangali Forward P/E|MDxHealth - Pangali mangsa ngarep rega marang bathi|LUCD (Lucid Diagnostics Inc.) - Pangali Forward P/E|PRE (Prenetics Global) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E IMDX|Rasio kapitalisasi marang bathi mangsa ngarep TRIB|Rega marang bathi mangsa ngarep ProPhase Labs Inc PRPH|Kapitalisasi marang proyeksi bathi Ainos Inc (AIMD)|CODX - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Heart Test Labs|BMRA: Pangali Forward P/E|CDIO - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Virax Biolabs|Bluejay Diagnostics, Inc. (BJDX) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Aspira Women's Health (AWH)|AXDX (Accelerate Diagnostics, Inc) - Pangali mangsa ngarep rega marang bathi|CENTOGENE, N.V. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ENZ|Pangali mangsa ngarep rega marang bathi fresh2.co (FRES)|GENE (Genetic Technologies Limited) - Rasio rega marang bathi mangsa ngarep|ME: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep PMD